Sign in
4

Changes in Ownership

Contineum Therapeutics, Inc. Filed Acc 0001437749-24-018626

Options or other derivatives

  • CEO and President acquired 285,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Stengone Carmine N. · CEO and President

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-05-24 Grant or award : show line 1 in the form Stock Option (right to buy) +285,000 285,000 D
Loading xslF345X05/rdgdoc.xml…